Corporate Banner
Satellite Banner
Biomolecular Screening
Scientific Community
 
Become a Member | Sign in
Home>Events>This Event
  Events - October 2013


European Pharmaceutical Pricing & Reimbursement

21 Oct 2013 - 22 Oct 2013 - London, UK



Bookmark and Share


We are delighted to announce SMi's European Pharmaceutical Pricing & Reimbursement. Now in its 19th year, this event has been one of the oldest market leaders in the pharmaceutical industries calendar for some time.

The agenda aims to bring together experts from key industry personnel from big Pharma, biotech and academia who will thoroughly explain and offer advice on P&R and market access. The conference will focus on European and US markets including country specific case studies proving strategic insight into how a wide range of complex issues can be readily adapted to.

This conference provides the most comprehensive up to date centre of information with reimbursement evidence inproduct development; Impact of HTA in different markets and international based price referencing.

KEY REASONS TO ATTEND

Understand how value based pricing will affect the U.Ks pricing market and what to expect

Discuss key market access strategies with a range of case studies including those currently being developed successfully with orphan drugs

Evaluate current strategies with the new NICE network reforms

See the establishment of the pan-European HTA network and its current effects

Develop future cross sector market access strategies


Register online here: www.smi-online.co.uk/2013europricing26.asp

Alternatively, contact: Jonathan Collins on +44 (0)20 7827 6734 or email: jcollins@smi-online.co.uk 

Academic & Group discounts available



Further information
Scientific News
Gene Terapy for Muscle Wasting Developed
New gene therapy could save millions of people suffering from muscle wasting disease.
Detecting Alzheimer's with Smell Test
Odour identification test may offer low-cost alternative for predicting cognitive decline and detecting early-stage Alzheimer’s disease.
Fighting Cancer Through Protein Pathways
Researchers have found a new drug target within a protein production pathway critical to regulating growth and proliferation of cells.
Mutations in DNA-Repair Genes Found in Advanced Prostate Cancers
New findings indicate that nearly 12% of male advanced prostate cancer sufferers have inherited mutation in DNA-repair genes.
Molecule May Affect Gaucher, Parkinson's Disease
Research has identified a molecule that restores activity of a dysfunctional enzyme linked to Gaucher and Parkinson's disease.
Targeting BRAF Mutations in Thyroid Cancer
Treating metastatic thyroid cancer patients harboring a BRAF mutation with vemurafenib showed anti-tumor activity in a third of patients.
Plant Compounds Fight Together Against Colon Cancer
Research shows treating colon cancer cells with curcumin, then silymarin is more effective than treatment with each individually.
New Centre Offers Ultra-Speed Protein Analysis
UW-Madison researchers to establish development centre for next-gen protein measurement technologies.
Drug Candidates Reduce Abnormal Protein Production
New drug candidates improve cell ability to catch miss-folded proteins that could cause deadly diseases.
Supercomputing and Drug Discovery
New biotech company uses supercomputer simulations to speed up drug discovery and biotech molecule development.
Scroll Up
Scroll Down
SELECTBIO

SELECTBIO Market Reports
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,300+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,900+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!